CompletedPhase 4NCT00181116
Levetiracetam for Benign Rolandic Epilepsy
Studying Self-limited epilepsy with centrotemporal spikes
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Johns Hopkins University
- Principal Investigator
- Eric H Kossoff, MD, M.DJohns Hopkins University
- Intervention
- Levetiracetam(drug)
- Enrollment
- 6 target
- Eligibility
- 6-12 years · All sexes
- Timeline
- 2005 – 2006
Study locations (1)
- Johns Hopkins Hospital, Baltimore, Maryland, United States
Collaborators
UCB Pharma
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00181116 on ClinicalTrials.govOther trials for Self-limited epilepsy with centrotemporal spikes
Additional recruiting or active studies for the same condition.
See all trials for Self-limited epilepsy with centrotemporal spikes →